Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1996-12-10
|
pubmed:abstractText |
Antiphospholipid antibodies (APA), lupus anticoagulant (LA) and/or anticardiolipin antibodies (ACA), are associated with thrombosis and recurrent miscarriage. We studied the outcome of 20 pregnancies in women (median age 32 years; range 23-41) with APA (14 LA positive; three immunoglobulin (Ig) G ACA positive; two IgM ACA positive and one LA and IgG ACA positive) and history of recurrent miscarriage (median 4; range 3-11) who declined pharmacological treatment in their next pregnancy. Comparison was made with a cohort of 100 consecutive women (median age 33 years; range 23-44) with recurrent miscarriage (median 4; range 3-10), in whom no underlying cause to account for their pregnancy losses was found. Of the 20 women with APA, 18 (90%) miscarried compared to 34 of the 100 women (34%) with normal investigations (P < 0.001). The majority (94%) of miscarriages in women with APA occurred in the first trimester. Fetal heart activity was seen prior to fetal death in 86% of women with APA compared to 43% of women with normal investigations (P < 0.01). The first trimester loss of embryonic pregnancies is the most common type of miscarriage in women with APA. This may be a result of defective implantation and subsequent placentation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0268-1161
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3301-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8822463-Abortion, Habitual,
pubmed-meshheading:8822463-Adult,
pubmed-meshheading:8822463-Antibodies, Anticardiolipin,
pubmed-meshheading:8822463-Antibodies, Antiphospholipid,
pubmed-meshheading:8822463-Antiphospholipid Syndrome,
pubmed-meshheading:8822463-Case-Control Studies,
pubmed-meshheading:8822463-Cohort Studies,
pubmed-meshheading:8822463-Female,
pubmed-meshheading:8822463-Fetal Death,
pubmed-meshheading:8822463-Humans,
pubmed-meshheading:8822463-Infant, Newborn,
pubmed-meshheading:8822463-Lupus Coagulation Inhibitor,
pubmed-meshheading:8822463-Pregnancy,
pubmed-meshheading:8822463-Pregnancy Outcome,
pubmed-meshheading:8822463-Prospective Studies
|
pubmed:year |
1995
|
pubmed:articleTitle |
High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, St Mary's Hospital Medical School, London, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|